GE HealthCare’s supply purchase still depends on outside customers
By OnTheRice · Sources and limitations · Report a correction
Buying SOFIE would give GE HealthCare more control over medical imaging supplies, while retaining outside suppliers and customers. Fluorine-18 tracers lose half their radioactivity in about 110 minutes, making nearby reliable production important. The deal has not closed, and FAPI-74 remains in Phase III trials; approval and higher profits are unproved.
Source confidenceNot assessed
What’s changing?
These imaging materials lose strength quickly, making reliable nearby supply useful. Outside customers and production partners remain important.
Key points
- Buying SOFIE would give GE HealthCare more control over medical imaging supplies, while retaining outside suppliers and customers.
- Fluorine-18 tracers lose half their radioactivity in about 110 minutes, making nearby reliable production important.
- The deal has not closed, and FAPI-74 remains in Phase III trials; approval and higher profits are unproved.
What could change this view?
- The deal has not closed. FAPI-74 remains in Phase III testing; approval and improved margins are unproved.
Bottom line
More likely direction: BULLISH over the next 24 hours.
This is based on the information recorded with this signal.
Terms in simple English
These explanations help you read this signal. The saved forecast, prices, deadline and outcome rules stay the same.
- Bullish
- OTR expects the price to rise during the stated time window. This is a forecast, not a promise.
- Watch or on confirmation
- The signal asks readers to watch for a stated condition. If it also says bullish or bearish, that direction still counts in the recorded outcome check.
- Entry or reference price
- The saved starting price used to check the forecast. A reference quote is not proof that a trade could be made at that price.
- HIT and MISS
- HIT means the price moved in the recorded direction under that call’s saved rules. MISS means it did not meet those rules. These labels do not measure profit after trading costs.
- Margin in context
- A business margin compares revenue with stated costs; it may be a percentage or profit per unit, such as dollars per barrel. For a leveraged trade, margin means money required to support the position. Check the stated measure.
- Utilisation
- How much of available capacity is actually used.
How likely is this call? · Three frameworks
GE HealthCare (GEHC) · BULLISH
Probability not recorded at publication. This earlier call is preserved without adding a hindsight estimate.
Evidence behind this view
Checks whether separate pieces of evidence support the same view.
Recorded connection
Fluorine-18 tracers lose half their radioactivity in about 110 minutes, making nearby, reliable supply important. GE HealthCare says it will retain other manufacturing partners and SOFIE will keep supplying other providers.
We have not established a separate count of independent evidence clusters for this card. Several reports may rely on the same event or data provider.
What past price moves show
Compares today’s price moves with recorded past patterns.
No asset-specific historical pattern test is recorded separately for this card.
Evidence against this view
Shows evidence and risks that could challenge this view.
Recorded opposing evidence and risks
The deal has not closed. FAPI-74 remains in Phase III testing; approval and improved margins are unproved.
Why the direction changed
Explains recorded changes from expecting a rise to expecting a fall, or the reverse.
No documented bullish-to-bearish or bearish-to-bullish change is available for this card. We keep the original call and its time unchanged.
What people say vs the facts
Compares recorded public discussion with checked market facts.
No separate Reddit or public-discussion comparison with verified market data is recorded for this card. We cannot treat social attention as proof of a market move.
How past forecasts performed
Shows recorded forecast results and what they can teach us.
Recorded outcomes for this signal: 0 HIT, 1 MISS, 0 other or pending. These counts are not a forecast probability.
No tested mapping from evidence combinations to future success is recorded for this card. Confidence in sources and past outcomes do not establish a calibrated probability.
Sources, original wording and price checks
Original research record
GE HealthCare agreed to pay US$945 million cash for SOFIE, with closing expected in the first half of 2027. The purchase would add 15 manufacturing sites, 21 cyclotrons and US rights to the experimental FAPI-74 imaging tracer.
Fluorine-18 tracers lose half their radioactivity in about 110 minutes, making nearby, reliable supply important. GE HealthCare says it will retain other manufacturing partners and SOFIE will keep supplying other providers.
OTR’s view: greater supply control does not remove the need to serve outside customers well. Network use and customer retention matter alongside ownership.
Investors: track the close, delivery reliability, use of the sites and retained outside customers.
The deal has not closed. FAPI-74 remains in Phase III testing; approval and improved margins are unproved.
Reliable supply and profitable use of the combined network would support the case.
Customer losses, delivery problems or excessive integration costs would weaken it.
GEHC: BULLISH / WATCH if supply reach produces profitable growth. Watch the expected 2027 close and later operating results. NO ENTRY.
Published
First published through Sites 06 Oct 2026, 12:18:23 SGT
24-hour check
- GE HealthCare (GEHC)BULLISH ✕ MISSPrice 1: 65.73000336 USD
At publication: 06 Oct 2026, 12:18:23 SGT
Price 2 (+24h): 64.82499695 USD
At +24h: 07 Oct 2026, 12:18:23 SGT
Change: -1.377%
Price 1 source: 06 Oct 2026, 03:59:00 SGT (offset -29963.693075 s)
Price 2 source: 07 Oct 2026, 03:59:00 SGT (offset -29963.693075 s)First published through Sites: 06 Oct 2026, 12:18:23 SGTCall and evidence
BULLISH / WATCH
The price fell between the nearest observations to publication and +24 hours; the bullish direction was incorrect.
Price series: GEHC · NasdaqGS. Nearest available one-minute candle opening price to each fixed endpoint. Offsets are disclosed; original call and deadline are unchanged.
Price 1 · at publicationExact endpoint: 06 Oct 2026, 12:18:23 SGT
65.73000336 USD · Nearest intraday candle (approximation)
Source quote: 65.73000336 USD · 06 Oct 2026, 03:59:00 SGT
Source observation ↗Offset from required time: -29963.693075 seconds. Negative means before; positive means after.
One-minute candle start; candle opening price. This is an approximation to the requested instant.
Price 2 · exactly +24 hoursExact endpoint: 07 Oct 2026, 12:18:23 SGT
64.82499695 USD · Nearest intraday candle (approximation)
Source quote: 64.82499695 USD · 07 Oct 2026, 03:59:00 SGT
Source observation ↗Offset from required time: -29963.693075 seconds. Negative means before; positive means after.
One-minute candle start; candle opening price. This is an approximation to the requested instant.
Change: -0.90500641 USD (-1.377%). The price fell between the nearest observations to publication and +24 hours; the bullish direction was incorrect.
Correction: Owner-requested full recalculation using nearest available intraday prices and disclosed offsets; includes previously settled calls. The previous result remains in the immutable assessment history.
Price-check terms in simple English
A reference is the saved starting quote. An endpoint is the comparison quote used for the result. A venue is the market or platform supplying that quote. A snapshot is a saved copy of the evidence at a stated time.
A one-minute price bar groups prices recorded within one minute; its close is the last price in that group. It does not prove a trade happened at the exact forecast time. A vendor is the data provider, and an execution price is the price of an actual trade.
Sign-only scoring checks whether the price rose or fell. A custom rule uses the separate saved conditions shown with that call. Supplied or owner-recorded evidence retains its stated limits; it is not automatically an independent check.
What changed
Recorded public historyBuying SOFIE would add manufacturing control while keeping outside partners and customers. Delivery reliability and customer retention are…
This is the first recorded public view. Further public updates will appear here.
- GE HealthCare’s supply purchase still depends on outside customers
Buying SOFIE would add manufacturing control while keeping outside partners and customers. Delivery reliability and customer retention are linked tests for the planned investment.
First published by OTR: 6 Oct, 12:18 SGTPublished by OTR: 6 Oct 2026, 12:18 SGT
Why the view changed
This is the first recorded view. Future source-backed updates will appear here.
Evidence, memory & review 1 linked source
What changed: GE HealthCare agreed to pay US$945 million cash for SOFIE, with closing expected in the first half of 2027. The purchase would add 15 manufacturing sites, 21 cyclotrons and US rights to the experimental FAPI-74 imaging tracer.
Named assets or actors: GE HealthCare (GEHC)
Directional takeaway: BULLISH / WATCH
OTR reasoning: Fluorine-18 tracers lose half their radioactivity in about 110 minutes, making nearby, reliable supply important. GE HealthCare says it will retain other manufacturing partners and SOFIE will keep supplying other providers.
Counterpoint: The deal has not closed. FAPI-74 remains in Phase III testing; approval and improved margins are unproved.
Source trail
- GE HealthCare agreement to acquire SOFIE ↗GE HealthCare5 October 2026; date only · source clock as displayed
Review status: APPROVED
This evidence panel does not assign a score or probability. Any forecast estimate is shown separately with its own source and limitations.